Takara Bio (FRA:TF2) FFO


FRA:TF2 Takara Bio Inc FRA:TF2
71 GF Score
Price €5.95
GF Value €4.46
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Takara Bio FFO?

FFO (Funds from operations) only applies to REITs.

FRA:TF2
71GF Score
Takara Bio Inc FRA:TF2
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Takara Bio (FRA:TF2) Overvalued in 2026?

Based on GuruFocus' analysis, Takara Bio stock appears to be overvalued. The current stock price of €5.95 is trading 33.4% above its estimated GF Value™ of €4.46. GuruFocus considers Takara Bio to be Significantly Overvalued.

Key valuation signals for FRA:TF2:

  • FFO:
  • GF Value™: €4.46 vs. price of €5.95 (33.4% above fair value)
  • GF Score™: 71/100 with 6 warning signs

No single metric tells the full story. See the FRA:TF2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Takara Bio Business Description

Other Exchanges 4974:Japan
Address Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, JPN, 520-0058
Takara Bio Inc is a biotechnology company that develops gene therapy procedures. The company reports in three business segments: Bioindustry, Gene therapy, and AgriBio. Takara's bioindustry business provides research reagents, scientific instruments, and various contracted services to universities and companies around the world. The company's gene therapy business is focused on treating cancer and HIV. Its AgriBio business aims to leverage biotechnologies in the food ingredient field, including large-scale mushroom production. The vast majority of Takara's revenue is derived from its bioindustry segment.
71GF Score

Get the complete analysis for FRA:TF2

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.95
Price
€4.46
GF Value